logo
Select company
Select metric
56.49%Capital Expenditures to Operating Cash Flow
VS
Market
26
Sector
17
Industry
18
History
-
$ 11.93Close
$ 10.13 - $ 21.29 52-Week Range
Ticker Information

Ticker

NRC

Company Name

NATIONAL RESEARCH CORP

Sector

Healthcare

Industry

Health Information Services

Exchange

NASDAQ

NATIONAL RESEARCH CORP - Capital Expenditures to Operating Cash Flow Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

NRC - CapEx/OCF Historical data
DateCapital ExpenditureCapital Expenditures to Operating Cash FlowNet Cash Flow - Operations
6/30/2025$ 12.04M56.49%$ 21.31M
3/31/2025$ 14.3M48.9%$ 29.23M
12/31/2024$ 15.45M44.62%$ 34.63M
9/30/2024$ 14.77M36.98%$ 39.95M
6/30/2024$ 17.65M43.74%$ 40.35M
3/31/2024$ 16.72M39.43%$ 42.4M
12/31/2023$ 15.78M41.4%$ 38.11M
9/30/2023$ 13.97M40.49%$ 34.51M
6/30/2023$ 13.49M38.82%$ 34.74M
3/31/2023$ 10.49M29.37%$ 35.73M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • NATIONAL RESEARCH CORP's latest trailing twelve months (TTM) CapEx/OCF stands at 10.07%.
  • Over the past 5 years, NATIONAL RESEARCH CORP's average CapEx/OCF has been 28.35%.
  • The median CapEx/OCF for NATIONAL RESEARCH CORP during this period was 28.24%
  • NATIONAL RESEARCH CORP reached its highest CapEx/OCF over the past 5 years at 56.49%.
  • The lowest CapEx/OCF recorded by NATIONAL RESEARCH CORP in the same timeframe 9.35%

NATIONAL RESEARCH CORP's CapEx/OCF vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx/OCF Benchmarks
CompanyCapEx/OCF
SPOK : SPOK HOLDINGS INC 12.1%OPRX : OPTIMIZERX CORP 3.26%CTMX : CYTOMX THERAPEUTICS INC -TALK : TALKSPACE INC 89.52%SLP : SIMULATIONS PLUS INC 22.91%RXST : RXSIGHT INC -PACB : PACIFIC BIOSCIENCES OF CALIFORNIA INC -AIRS : AIRSCULPT TECHNOLOGIES INC 101.9%ARCT : ARCTURUS THERAPEUTICS HOLDINGS INC -LFCR : LIFECORE BIOMEDICAL INC -

Definition of Capital Expenditures to Operating Cash Flow

[Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
CapEx / CF - Operations
(=) CapEx/OCF
CapEx/OCF for NATIONAL RESEARCH CORP is calculated as follows: CapEx [ $ 3.66M ] / CF - Operations [ $ 36.36M ]
(=) CapEx/OCF [ 10.07% ]

NRC - Capital Expenditures to Operating Cash Flow, Last 5 years

9.35%

Minimum

Mar 31, 2021

56.49%

Maximum

Jun 30, 2025

28.35%

Average

28.24%

Median

CapEx/OCF Benchmark Analysis

The chart above depicts the distribution of CapEx/OCF for companies in the Total Stock Market. The average CapEx/OCF of the companies is 31.8% with a standard deviation of 29.52%.
The following table provides additional summary stats:
CapEx/OCF in the Market:
filtered constituents2.35K
min0.01%
max128%
average31.8%
median22.41%
std29.52%